A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)

A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition) - A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051501

Enrollment

180

Registered

2023-07-03

Start date

2023-07-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Those who have given their free and voluntary written consent to participate in this study. 2)Men and women who are 18 years of age or older at the time consent is obtained. 3)Persons who have lipid abnormalities or have been diagnosed with dyslipidemia 4)Patients whose fasting blood collection measurements in Visit 1 (SCR) meet any of the following. -LDL cholesterol 70 mg/dL or higher -HDL cholesterol less than 40mg/dL -TG 150 mg/dL or more, but less than 400 mg/dL 5)Patients who agree not to change the dosage and administration of the treatment for lipid disorders during the study period (V1 to V3).

Exclusion criteria

Exclusion criteria: 1)Patients with malignant tumors within the past 10 years 2)Persons deemed ineligible by the study physician

Design outcomes

Primary

Measure	Time frame
To understand the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol	—

Secondary

Measure	Time frame
The impact of communicating their own target values for the management of LDL-Cholesterol to dyslipidemic patients on various lipid parameters(LDL-C,HDLC,Non-HDL-C,TG).	—

Countries

Japan

Contacts

Public ContactHirotaka Nagashima

TOKYO CENTER CLINIC Clinical Research Group

shimizu_satoko@tc-clinic.jp0332766935

Outcome results